Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,321,520 papers from all fields of science
Search
Sign In
Create Free Account
flumizole
Known as:
4,5-bis(p-methoxyphenyl)-2-(trifluoromethyl)imidazole
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Imidazoles
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
TXA2-antagonistic properties of agents affecting prostaglandin synthesis or the cyclic nucleotide system in human platelets.
M. Kangasaho
,
H. Vapaatalo
Acta Pharmacologica et Toxicologica
2009
Corpus ID: 12599549
Prostaglandins (PG) E1 and E2 as well as 3-isobutyl-1-methylxanthine, nitroprusside, dibutyryl cyclic AMP and N-0164 inhibited…
Expand
1985
1985
5,6-Diaryl-2,3-dihydroimidazo[2,1-b]thiazoles: a new class of immunoregulatory antiinflammatory agents.
P. Bender
,
D. Hill
,
+7 authors
D. T. Walz
Journal of Medicinal Chemistry
1985
Corpus ID: 2141551
A series of substituted 5,6-diaryl-2,3-dihydroimidazo[2,1-b]thiazoles were synthesized and evaluated in the rat adjuvant-induced…
Expand
1983
1983
Antipyretic analgesics and the allergic patient.
A. Szczeklik
American Journal of Medicine
1983
Corpus ID: 23371001
1978
1978
Disposition and activity in experimental allergic encephalomyelitis of flumizole, a nonacidic, nonsteroidal, anti-inflammatory agent
H. Mcilhenny
,
S. Levine
,
E. H. Wiseman
,
R. Sowinski
Experimental Neurology
1978
Corpus ID: 43485736
1975
1975
Flumizole, a new nonsteroidal anti-inflammatory agent.
E. H. Wiseman
,
H. Mcilhenny
,
J. Bettis
Journal of Pharmacy and Science
1975
Corpus ID: 24017163
Flumizole is a potent anti-inflammatory agent in animal models with an inhibitory activity severalfold that of indomethacin in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE